Sacubitril-Valsartan Improves Cardiac Function Despite Kidney Decline in HFrEF Patients, study reveals Medha Baranwal10 Nov 2024 9:00 PM ISTSouth Korea: A recent study published in Kidney Research and Clinical Practice has shed light on the impact of sacubitril-valsartan therapy on cardiac...
Study Reveals Association Between Cardiac Arrhythmias and Macular Degeneration Risk Medha Baranwal5 Nov 2024 8:45 AM ISTUSA: A recent study presented at the annual meeting of the American Academy of Ophthalmology, which took place from October 18 to 21 in Chicago, found...
TAVR in patients with systolic HF and moderate AS shows limited benefits, claims research Dr. Kamal Kant Kohli2 Nov 2024 9:00 AM ISTFindings from the TAVR UNLOAD study found limited benefits of transcatheter aortic valve replacement (TAVR) in the treatment of heart failure (HF)...
Abbott initiates new clinical trial to improve outcomes in patients with advanced Heart Failure Ruchika Sharma31 Oct 2024 2:00 PM ISTAbbott Park, Ill.: Abbott has announced a new, first-of-its-kind clinical trial designed to improve outcomes in patients with worsening heart...
Right Turn Show - Optimal Use of Dapagliflozin and its Combinations in Specialty Care Settings MD Brand Connect30 Oct 2024 10:00 AM ISTBringing you the 'Right Turn Show,' where we focus on the optimal use of dapagliflozin and its combinations in speciality care settings. In this...
Interrelation between Heart Failure and Cancer may need Multidisciplinary Approach, suggests study Dr.Niharika Harsha B29 Oct 2024 8:45 AM ISTA recent scientific statement from the Heart Failure Society of America discussed the various risk factors, mechanisms, diagnosis, and management...
Once-Weekly Semaglutide Cuts Heart Failure Risk in Diabetes and Kidney Disease: FLOW Trial Analysis Medha Baranwal29 Oct 2024 8:00 AM ISTUSA: In a significant advancement for cardiovascular care, the FLOW trial has demonstrated that semaglutide, a glucagon-like peptide-1 receptor...
SGLT2 inhibitor canagliflozin has Heart and kidney benefits among patients across all age categories: Study Dr Kartikeya Kohli28 Oct 2024 8:30 PM ISTSodium-glucose co-transporter 2 (SGLT2) inhibitors reduce the risk of cardiovascular and kidney outcomes in patients with type 2 diabetes, but it is...
Sacubitril/Valsartan Safe to Continue Even with GFR Below 30 ml/min in HF Patients: Research Finds Dr. Garima Soni28 Oct 2024 10:57 AM ISTUSA: Recent research indicates that sacubitril/valsartan can be safely continued in heart failure patients, maintaining cardiovascular and kidney...
Vericiguat Lowers Cardiovascular Death Risk in Heart Failure Patients, Independent of Diabetes: VICTORIA Trial Analysis Medha Baranwal24 Oct 2024 9:00 AM ISTUSA: The recent analysis from the VICTORIA trial has highlighted the potential benefits of vericiguat in managing cardiovascular (CV) outcomes for...
Standing more may not reduce CVD risk, could increase circulatory disease: Study Dr. Kamal Kant Kohli18 Oct 2024 9:00 PM ISTStanding has gained popularity among people looking to offset the harms of a sedentary lifestyle often caused by spending long days sitting in front...
Finerenone improves long-term survival benefits in patients with worsening heart failure, finds study Jacinthlyn Sylvia18 Oct 2024 8:00 AM ISTA recent study published in the Journal of American Medical Association showed a projection that long-term finerenone medication can increase...
